全文获取类型
收费全文 | 3664篇 |
免费 | 109篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 76篇 |
妇产科学 | 54篇 |
基础医学 | 437篇 |
口腔科学 | 4篇 |
临床医学 | 271篇 |
内科学 | 1258篇 |
皮肤病学 | 476篇 |
神经病学 | 67篇 |
特种医学 | 43篇 |
外科学 | 316篇 |
综合类 | 439篇 |
预防医学 | 107篇 |
眼科学 | 58篇 |
药学 | 167篇 |
中国医学 | 53篇 |
肿瘤学 | 24篇 |
出版年
2024年 | 3篇 |
2023年 | 30篇 |
2022年 | 75篇 |
2021年 | 84篇 |
2020年 | 93篇 |
2019年 | 104篇 |
2018年 | 103篇 |
2017年 | 91篇 |
2016年 | 75篇 |
2015年 | 97篇 |
2014年 | 154篇 |
2013年 | 203篇 |
2012年 | 185篇 |
2011年 | 200篇 |
2010年 | 193篇 |
2009年 | 230篇 |
2008年 | 202篇 |
2007年 | 209篇 |
2006年 | 198篇 |
2005年 | 192篇 |
2004年 | 195篇 |
2003年 | 149篇 |
2002年 | 139篇 |
2001年 | 113篇 |
2000年 | 92篇 |
1999年 | 81篇 |
1998年 | 37篇 |
1997年 | 41篇 |
1996年 | 29篇 |
1995年 | 37篇 |
1994年 | 33篇 |
1993年 | 24篇 |
1992年 | 13篇 |
1991年 | 19篇 |
1990年 | 21篇 |
1989年 | 26篇 |
1988年 | 9篇 |
1987年 | 17篇 |
1986年 | 10篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1982年 | 7篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1972年 | 2篇 |
1906年 | 1篇 |
排序方式: 共有3854条查询结果,搜索用时 11 毫秒
31.
Hideo Kawahara Yasuo Kokubo Takafumi Yayama Kenzo Uchida Shigeru Kobayashi Hideaki Nakajima Hisashi Oki Kohei Negoro Erisa S. Mwaka Norbert T. Orwotho Hisatoshi Baba 《Artificial organs》2010,34(5):377-383
Using a nonlinear three‐dimensional finite element analysis simulating loading conditions, we designed a new type of proximal‐fitting, anterolaterally‐flared, arc‐deposit hydroxyapatite‐coated anatomical femoral stem (FMS‐anatomic stem; Japan Medical Materials, Osaka, Japan) for cementless total hip arthroplasty (THA) for Japanese patients with dysplastic hip osteoarthritis. The aim of the present study was to analyze the clinical and radiographic outcomes of the new stem. We reviewed 143 consecutive patients (164 hips; 13 men, 14 hips; 130 women, 150 hips; age at surgery, 56.6 ± 7.6 years, mean ± SD, range, 30–74) who underwent cementless THA using the FMS‐anatomic stem at a single institution, with a follow‐up period of 7.6 ± 1.6 years (range, 5.3–11.0). Harris Hip score improved from 46.1 ± 12.6 before surgery to 90.0 ± 8.9 points post‐THA. The 7.6‐year survival rate of the stem was 99.0% after revision for aseptic loosening. Radiographs at follow‐up confirmed the stability of the femoral stems within the femoral canal in all cases, with sufficient bone ingrowth. None of the patients had subsidence of the stem exceeding 2.0 mm within the femoral canal or changes in varus or valgus position of more than 2.0°. The FMS‐anatomic stem provided excellent results in patients with dysplastic hip osteoarthritis. Our analysis confirmed reduced radiolucency around the stem in Gruen zones, minimal subsidence, appropriate stress shielding, and promising medium‐term stability within the femoral canal in our patients. 相似文献
32.
目的 探讨系统性红斑狼疮(SLE)并发股骨头坏死(ONFH)的临床特点和危险因素.方法 对我院确诊的376例SLE患者的临床及随访资料进行回顾性分析,以了解SLE合并ONFH的患病情况和危险因素.结果376例SLE股骨头坏死的发病率为7.18%(27/376),其中双侧16例(59.26%),单侧11例(40.74%);其危险因素包括口腔溃疡、雷诺氏现象、血管炎、TC、TG、累积激素用量及是否行激素冲击;在随访分析中,大剂量激素冲击治疗组患者股骨头缺血坏死终点事件的发生率显著高于非大剂量激素冲击治疗组,分别为12.50%比5.92%(P<0.05).结论 SLE患者发生股骨头坏死的危险性相对较高,血管炎、口腔溃疡、雷诺氏现象、高脂血症、激素治疗是其危险因素,尤其是大剂量糖皮质激素冲击治疗. 相似文献
33.
目的探讨抗核小体抗体与狼疮肾炎活动性的关系。方法对2007年4月至2009年12月在我院住院的75例经肾活检确诊为狼疮肾炎患者的临床资料进行回顾性研究。结果抗核小体抗体在活动性增殖性狼疮肾炎中的阳性率(59.3%)较非活动性增殖性狼疮肾炎(27.3%)和非增殖性狼疮肾炎(20.0%)高(P〈0.05)。活动性狼疮肾炎组的抗核小体抗体阳性率(53.8%)较非活动性狼疮‘肾炎组阳性率(23.8%)高(P〈0.05)。抗核小体抗体阳性组的病理活动性指数(active index,AI)较阴性组高(P〈0.05),两组慢性指数(chronic index.CI)和狼疮肾炎的临床活动性评分(renalactivity score,RAS)无显著差异(P〉0.05)。结论抗核小体抗体与狼疮肾炎的病理活动性相关,在活动性增殖性狼疮肾炎中出现较为普遍,是提示活动性增殖性狼疮肾炎的一项重要的指标。 相似文献
34.
Nathanson S Salomon R Ranchin B Macher MA Lavocat MP Krier MJ Baudouin V Azéma C Bader-Meunier B Deschênes G 《Pediatric nephrology (Berlin, Germany)》2006,21(8):1113-1116
The occurrence of membranous nephropathy in pediatric series of systemic lupus erythematosus has been reported only rarely, probably due to a very low frequency. One hundred fifty-four children who were seen in 100 French pediatric centers between January 2002 and April 2005 were included. Fifteen (12 girls and three boys) out of the 81 (18.5 %) children with renal involvement presented histological features of membranous nephropathy. Their ages ranged from six to 15 years old (mean=11.3) at the age of SLE diagnosis and 8/15 children were of African origin. Isolated membranous nephropathy was observed in nine patients, of whom five patients displayed a complete recovery following immunosuppressive treatment. Associated proliferative lesions were observed on the first kidney specimen in two patients and in a further renal biopsy in four other patients, leading to a less favorable course of lupus nephropathy. 相似文献
35.
36.
M. Sawamura S. Yamaguchi H. Murakami H. Amagai T. Matsushima J. Tamura T. Naruse J. Tsuchiya 《Annals of hematology》1994,68(5):251-254
Summary We report on a patient with splenic lymphoma of B-cell origin who developed autoimmune hemolytic anemia (AIHA). IgM M-protein, IgM anticardiolipin antibody (ACA), and lupus anticoagulant (LA) were detected in the serum, and direct Coombs' test showed autoantibodies of the IgG1 and IgG2 subclasses on red blood cells (RBC). In in vitro culture, tumor cells isolated from the spleen produced only IgM ACA, which was enhanced by IL-6 but not by IL-4 or IL-5. The levels of ACA and LA decreased after splenectomy and chemotherapy; the strength of the direct Coombs' test, however, did not change. These findings indicated that in this patient the lymphoma cells produced IgM. ACA, but not autoantibodies of the IgG1 and IgG2 subclasses against RBC. It was also suggested that IL-6 might at least partially stimulate the production of ACA. 相似文献
37.
The effect of intravenous cyclophosphamide pulse on peripheral blood lymphocytes in lupus erythematosus patients 总被引:1,自引:0,他引:1
In the present study we investigated the long-term effect of intravenous pulse cyclophosphamide (CY) on lymphocyte surface
antigens in systemic lupus erythematosus (SLE) patients. Blood samples derived from 17 lupus erythematosus patients were analysed
using two- and three-colour flow cytometry. During the CY therapy, the total number of T lymphocytes (CD3+) was reduced by
31.4%, B lymphocytes (CD19+) by 67.4% and NK cells (CD16+) by 27.4%. Six months after the end of the CY regimen, these values
recovered to entry levels. At the onset of the study we observed increased percentages of CD3+ CD25+, CD3+ CD4– CD8–, CD4+
CD29+, CD19+ and CD19+ CD5+ cells. The CY treatment regimen decreased the CD3+ CD25+, CD3+ CD4– CD8–, CD19+ and CD19+ CD5+
cells, but increased the CD3+ CD8+ subpopulation. Taken together, a deficiency of CD8+ T cells associated with CD4+ CD29+
predominance may imply an immune regulatory imbalance leading to abnormal CD4+ cell activation and in consequence to autoimmunity.
Depletion of CD19+ cells combined with an enlargement of CD8 cells as a result of CY therapy may reduce the enhanced immune
response in SLE patients.
Received: 13 December 1996 / Accepted: 10 March 1997 相似文献
38.
目的研究不同免疫途径对马疫锥虫动基体DNA(kDNA)诱导正常小鼠产生抗双链DNA(dsDNA)抗体及其致病性的影响。方法将马疫锥虫kDNA与不完全弗氏佐剂乳化混合,通过皮下、腹腔、肌肉及静脉等途径注射入正常BALB/C小鼠。8周后,检测小鼠血清抗dsDNA抗体亚型及滴度、血尿素氮(BUN)、血肌酐(Scr)、补体C3、24h尿蛋白浓度、肾小球免疫复合物沉积强度、肾组织病变活动指数等,并分析肾组织病理学特征。结果上述各组小鼠产生IgG型抗dsDNA抗体量及肾损害程度依次为:皮下组>腹腔组>肌肉组>静脉组(P<0.05);IgG型抗dsDNA抗体与肾组织病变活动指数呈正相关。结论不同免疫途径对马疫锥虫kDNA诱导抗dsDNA抗体产生有明显不同影响,其导致的狼疮样肾脏损害与该抗体亚型有关。 相似文献
39.
《The Egyptian Rheumatologist》2022,44(2):151-157
Aim of the workTo assess urinary soluble CD163 (sCD136) in systemic lupus erythematosus (SLE) patients compared to healthy controls. In addition to determine its association with different SLE clinical features, laboratory investigations and pathological indices focusing on those suggest renal disease activity.Patients and methodsThe study included 58 SLE patients and 30 controls. SLE disease activity index (SLEDAI) was assessed and patients subdivided into active lupus nephritis (ALN) (renal SLEDAI ≥ 4) and no-renal activity (NRA) SLE patients (renal SLEDAI = 0). Urinary sCD163 was measured by Enzyme-Linked Immunosorbent Assay (ELISA). Urine values were normalized to urinary creatinine excretion. Renal biopsies were performed in 21 ALN patients.ResultsThey were 54 females and 4 males with a mean age 31.8 ± 9.1 years and disease duration 6.2 ± 4.8 years. They were 31 with ALN and 27 NRA SLE patients. Urinary sCD163 level was significantly higher in SLE patients (1.85 ± 0.3) than controls (0.5 ± 0.36, p < 0.001). In ALN, it was significantly higher (2.91 ± 2.52) compared to NRA SLE patients (0.64 ± 0.38) and controls (p < 0.001 in both). The optimum cut-off value above which normalized urinary sCD136 can predict renal activity was > 0.82 with sensitivity of 90.3%, specificity of 88.89%, p < 0.001. Urinary sCD163 significantly correlated with renal (r = 0.75, p < 0.001) but not with extra-renal SLEDAI. It correlated with activity index of renal biopsy (r = 0.46, p = 0.038).ConclusionUrinary sCD163 is a potential biomarker for LN activity. Its level is associated with clinical features, laboratory investigations and pathological indices that indicate renal disease activity. 相似文献
40.
Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment 总被引:1,自引:0,他引:1
Dr. K. Wildhagen K. Hartung M. Hammer W. Mau R. E. Schmidt H. Deicher H. Zeidler 《Clinical rheumatology》1993,12(2):265-267
Summary The induction of lupus-like syndromes with the appearance of single-stranded DNA antibodies is a well-known complication of drug therapy. In this report we present a patient with an erosive seropositive rheumatoid arthritis developing the clinical and serological features of systemic lupus erythematosus including the occurrence of double-stranded DNA antibodies under sulfasalazine treatment. 相似文献